ONYA THERAPEUTICS LIMITED

Active United Kingdom

Research and experimental development on biotechnology

7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
O

ONYA THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 5 Feb 2020 Active United Kingdom 7 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 5 months remaining
Confirmation Submitted 30 Mar 2026 Next due 18 Feb 2027 9 months remaining
Net assets £-1M £67K 2024 year on year
Total assets £311K £141K 2024 year on year
Total Liabilities £1M £208K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for ONYA THERAPEUTICS LIMITED (12443293), an active life sciences and medical technology company based in United Kingdom. Incorporated 5 Feb 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£190.87k

Increased by £149.37k (+360%)

Net Assets

-£1.10M

Decreased by £67.16k (-7%)

Total Liabilities

£1.41M

Increased by £208.32k (+17%)

Turnover

N/A

Employees

7

Debt Ratio

453%

Decreased by 254 (-36%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2025Seed
Investor 2Jan 2025Seed

Share Capital

Share Capital

Share allotments and capital structure

66 Allotments 6,388,359 Shares £13.22m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
31 Dec 2025123,071£186k£186k
31 Dec 202518,858£186k£186k
31 Dec 2025123,071£186k£186k
31 Dec 202518,858£186k£186k
31 Dec 2025123,071£186k£186k

Officers

Officers

3 active
Status
Hafner, Thomas ChristianDirectorGermanUnited Kingdom625 Feb 2020Active
Marron, Damian JohnDirectorBritishFrance631 Dec 2022Active
Pigg, William, DrDirectorBritishEngland6410 Aug 2020Active

Shareholders

Shareholders (12)

Ctl Familienstiftung
92.2%
2,580,511
Patrick Tilley
2.3%
64,474

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Mr Timothy Calvin Hafner

Dutch

Active
Notified 17 Nov 2025
Residence Malta
DOB February 1999
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Mr Lucas Maximilian Hafner

Dutch

Active
Notified 17 Nov 2025
Residence Malta
DOB January 2001
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Neem Biotech Ltd

Ceased 1 Jan 2022

Ceased

Ctl Familienstiftung

Ceased 17 Nov 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026OfficersAppointment of Mr Blaz Gorjup as director on 2026-03-30
1 Apr 2026CapitalAllotment of shares (GBP 6.549526) on 2026-02-11
30 Mar 2026Confirmation StatementConfirmation statement made on 2026-02-04 with updates
28 Mar 2026CapitalCapital Name Of Class Of Shares
18 Mar 2026CapitalAllotment of shares (GBP 6.544834) on 2025-12-31
23 Apr 2026 Officers

Appointment of Mr Blaz Gorjup as director on 2026-03-30

1 Apr 2026 Capital

Allotment of shares (GBP 6.549526) on 2026-02-11

30 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-02-04 with updates

28 Mar 2026 Capital

Capital Name Of Class Of Shares

18 Mar 2026 Capital

Allotment of shares (GBP 6.544834) on 2025-12-31

Recent Activity

Latest Activity

Appointment of Mr Blaz Gorjup as director on 2026-03-30

2 days ago on 23 Apr 2026

Allotment of shares (GBP 6.549526) on 2026-02-11

3 weeks ago on 1 Apr 2026

Confirmation statement made on 2026-02-04 with updates

3 weeks ago on 30 Mar 2026

Capital Name Of Class Of Shares

4 weeks ago on 28 Mar 2026

Allotment of shares (GBP 6.544834) on 2025-12-31

1 months ago on 18 Mar 2026